カテゴリ： GlobalData, 世界, 医療/バイオ

胆嚢炎(Cholecystitis)：世界の治験レビュー（2015年上半期版）

調査会社GlobalData社が発行したリサーチレポート（データ管理コード：GDHC2639CTIDB）
◆英語タイトル：Cholecystitis Global Clinical Trials Review, H1, 2015
◆発行会社/調査会社：GlobalData
◆商品コード：GDHC2639CTIDB
◆発行日：2015年4月17日
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆ページ数：69
◆レポート言語：英語
◆レポート形式：PDF
◆納品方式：Eメール
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥275,000見積依頼/購入/質問フォーム
Site License（同一国内共有可）USD5,000 ⇒換算￥550,000見積依頼/購入/質問フォーム
Enterprisewide License（複数国内共有可）USD7,500 ⇒換算￥825,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[胆嚢炎(Cholecystitis)：世界の治験レビュー（2015年上半期版）]についてメールでお問い合わせはこちら
当調査レポートでは、世界における胆嚢炎(Cholecystitis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
　　- 胆嚢炎(Cholecystitis)
　　- 当レポートの概要
・胆嚢炎(Cholecystitis)：各地域別治験状況
　　- 各国の治験件数及び平均被験者数
　　 アジア太平洋の主要国における治験件数
　　 欧州の主要国における治験件数
　　 北米の主要国における治験件数
　　 中東・アフリカの主要国における治験件数
　　 中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数：段階別
・G7諸国での治験件数：進捗状況別
・段階(フェーズ)別の治験件数：進行中の治験（段階別）
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
　　- 代表的な企業における治験概要
　　- 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
*** レポート概要（サマリー）***

Cholecystitis Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Cholecystitis Global Clinical Trials Review, H1, 2015″ provides data on the Cholecystitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholecystitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholecystitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

*** レポート目次（コンテンツ）***

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cholecystitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cholecystitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cholecystitis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cholecystitis 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Cholecystitis Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Pfizer Inc. 32
Clinical Trial Overview of Pfizer Inc. 32
Johnson & Johnson 33
Clinical Trial Overview of Johnson & Johnson 33
Bayer AG 34
Clinical Trial Overview of Bayer AG 34
USGI Medical, Inc. 35
Clinical Trial Overview of USGI Medical, Inc. 35
Otsuka Holdings Co., Ltd. 36
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Fujifilm Holdings Corporation 38
Clinical Trial Overview of Fujifilm Holdings Corporation 38
Clinical Trial Overview of Top Institutes / Government 39
Karolinska University Hospital 39
Clinical Trial Overview of Karolinska University Hospital 39
Mansoura University 40
Clinical Trial Overview of Mansoura University 40
St. Antonius Hospital 41
Clinical Trial Overview of St. Antonius Hospital 41
Tehran University of Medical Sciences 42
Clinical Trial Overview of Tehran University of Medical Sciences 42
Asan Medical Center 43
Clinical Trial Overview of Asan Medical Center 43
Babol University of Medical Sciences 44
Clinical Trial Overview of Babol University of Medical Sciences 44
Beijing You An Hospital, Capital Medical University 45
Clinical Trial Overview of Beijing You An Hospital, Capital Medical University 45
Bezmialem Vakif University 46
Clinical Trial Overview of Bezmialem Vakif University 46
Centre Hospitalier Universitaire, Amiens 47
Clinical Trial Overview of Centre Hospitalier Universitaire, Amiens 47
Chiba University 48
Clinical Trial Overview of Chiba University 48
Five Key Clinical Profiles 49
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables
Cholecystitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Cholecystitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholecystitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholecystitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Cholecystitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Cholecystitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Cholecystitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Cholecystitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Cholecystitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholecystitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholecystitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholecystitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholecystitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholecystitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholecystitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Cholecystitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Cholecystitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholecystitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholecystitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Cholecystitis Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Cholecystitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Cholecystitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Cholecystitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Cholecystitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Cholecystitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 32
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 33
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by USGI Medical, Inc., 2015* 35
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 36
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Fujifilm Holdings Corporation, 2015* 38
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska University Hospital, 2015* 39
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mansoura University, 2015* 40
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Antonius Hospital, 2015* 41
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 42
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 43
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Babol University of Medical Sciences, 2015* 44
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing You An Hospital, Capital Medical University, 2015* 45
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bezmialem Vakif University, 2015* 46
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire, Amiens, 2015* 47
Cholecystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 48

List of Figures
Cholecystitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Cholecystitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Cholecystitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Cholecystitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Cholecystitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Cholecystitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Cholecystitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Cholecystitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Cholecystitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Cholecystitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Cholecystitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Cholecystitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Cholecystitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Cholecystitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Cholecystitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Cholecystitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Cholecystitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Cholecystitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Cholecystitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Cholecystitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Cholecystitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Cholecystitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Cholecystitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 68

*** レポートのキーワード ***

胆嚢炎(Cholecystitis)、治験、臨床試験、治験、治療薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連調査資料はありません。

※おすすめ調査資料
 ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(GDHC2639CTIDB )"胆嚢炎(Cholecystitis)：世界の治験レビュー（2015年上半期版）" (英文：Cholecystitis Global Clinical Trials Review, H1, 2015)はGlobalData社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ（登録第5864124号）及びH&I（登録第5783645号）はH&Iグローバルリサーチ株式会社の商標です。